Telomir Pharmaceuticals, Inc. Common Stock (TELO) — Net Asset Quality Index
Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a Net Asset Quality Index of 85.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $5.79 Million minus total liabilities of $827.31K yields net assets of $4.96 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Telomir Pharmaceuticals, Inc. Common Sto defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Telomir Pharmaceuticals, Inc. Common Stock Net Asset Quality Index Over Time (2021–2025)
This chart shows how Telomir Pharmaceuticals, Inc. Common Stock's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 85.7%, representing net assets of $4.96 Million against total assets of $5.79 Million USD. Explore TELO cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Telomir Pharmaceuticals, Inc. Common Stock (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Telomir Pharmaceuticals, Inc. Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Telomir Pharmaceuticals, Inc. Common Sto (TELO) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.5% | $5.91 Million | $7.34 Million | $1.43 Million | ▲ +32.0 pp |
| 2024 | 48.6% | $643.04K | $1.32 Million | $680.97K | ▼ -23.5 pp |
| 2023 | 72.0% | $3.44 Million | $4.77 Million | $1.34 Million | ▲ +1995.4 pp |
| 2022 | -1923.4% | $-937.28K | $48.73K | $986.01K | ▼ -1772.3 pp |
| 2021 | -151.1% | $-83.13K | $55.00K | $138.13K | — |